---
title: "BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292497368.md"
description: "BMO Capital analyst Evan Seigerman reaffirmed a Buy rating on Vertex Pharmaceuticals (VRTX) with a $600 price target. Concurrently, Wells Fargo's Mohit Bansal issued a Buy rating for the company. However, Needham maintained a Hold rating on VRTX as of July 7."
datetime: "2026-07-13T13:38:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292497368.md)
  - [en](https://longbridge.com/en/news/292497368.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292497368.md)
---

# BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $600.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Seigerman covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Incyte. According to TipRanks, Seigerman has an average return of 7.8% and a 54.25% success rate on recommended stocks.

In addition to BMO Capital, Vertex Pharmaceuticals also received a Buy from Wells Fargo’s Mohit Bansal in a report issued today. However, on July 7, Needham maintained a Hold rating on Vertex Pharmaceuticals (NASDAQ: VRTX).

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [BMO.US](https://longbridge.com/en/quote/BMO.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans](https://longbridge.com/en/news/293268909.md)
- [$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/292820592.md)
- [Citi Sticks to Its Buy Rating for Quanta Services (PWR)](https://longbridge.com/en/news/293614489.md)
- [New Buy Rating for Steel Dynamics (STLD), the Basic Materials Giant](https://longbridge.com/en/news/293479884.md)
- [BMO Capital Sticks to Their Buy Rating for TC Energy (TRP)](https://longbridge.com/en/news/293034066.md)